Global Contraceptive Drugs Market Report By Age Group (15-24 years, 25-34 years, 35-44 years, Above 44 years), By Product (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives), By End User (Homecare, Hospitals, Clinics) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2022-2030
The global demand for Contraceptive Drugs Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Contraceptive drugs are one of the strategies for birth control and are used to prevent pregnancy. Contraceptive drugs are operated by people to avoid sexually transmitted infections (STIs) and for birth control and family planning. Oral pills, injectable contraceptives, and topical contraceptives are all contraceptive drugs. These drugs are used by women of childbearing age between the ages of 15 and 44, following puberty and before menopause. Oral contraceptives are hormonal preparations that include either a combination of estrogen and progestin or simply progestin. Contraceptive drugs are both inexpensive and effective and provide other health benefits. During fertilization, the contraceptive pill prevents sperm from uniting with an egg.
An increase in worries about family planning and the need to prevent unplanned pregnancy are key factors driving the worldwide contraceptive drug market's growth. Furthermore, an increase in the usage of contraception among young women and a rise in educational attainment help drive market expansion. In addition, health issues associated with teenage pregnancies increased awareness of modern contraception methods, and increased use of oral tablets are likely to drive market expansion in the following years. Contraceptive drug market growth is hampered by health hazards connected with contraceptives.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of contraceptive drugs. The growth and trends of contraceptive drugs industry provide a holistic approach to this study.
This section of the contraceptive drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Age Group
Above 44 Years
Oral Contraceptive Pills
By End User
This section covers the regional outlook, which accentuates current and future demand for the Contraceptive Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Contraceptive Drugs Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the contraceptive drugs market include Agile Therapeutics, Allergan Plc., Bayer AG, GlaxoSmithKline Plc, Johnson & Johnson, Piramal Healthcare, Mylan N.V., Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . CONTRACEPTIVE DRUGS – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Age Group
3.7.2 Market Attractiveness Analysis By Product
3.7.3 Market Attractiveness Analysis By End User
3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
Frequently Asked Questions (FAQs) about this Report
The global Contraceptive Drugs market size was worth USD 12,500 Million in 2021.
For the years 2023-2028, the global Contraceptive Drugs market growth is expected to be around 5.1%.
The Global Contraceptive Drugs Market is currently dominated by North America.
The Global Contraceptive Drugs is segmented by Age Group, 15–24 years, 25–34 years, 35–44 years, Above 44 years, by Product, Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives, by End User, Homecare, Hospitals, Clinics.
The leading players in the Global Contraceptive Drugs Market are Agile Therapeutics, Allergan Plc., Bayer AG, GlaxoSmithKline Plc, Johnson & Johnson, Piramal Healthcare, Mylan N.V., Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd.